Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.87)
# 1,726
Out of 4,915 analysts
2
Total ratings
100%
Success rate
33.43%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $7.10
Upside: +40.94%